Reveal HealthTech, a healthcare-focused AI transformation partner, has raised $7.2 million in Series A funding led by Leo Capital, with participation from Sanos Capital. Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company has rapidly emerged as a specialist at the intersection of advanced AI innovation and deep healthcare expertise.
Reveal partners with healthcare organizations to identify high-value challenges and design safe, clinically relevant AI systems that address them.
“Every year, across hundreds of thousands of patient touchpoints, we’ve seen the profound impact that compassion and intelligence can have when woven into care. At Essen Health Care, we have long envisioned what it would mean if every interaction reflected empathy and personalization. With Reveal, that vision is becoming reality. By acting on data in real-time, we’re not only improving patient experiences but also easing the burden on clinicians,” said Dr. Sumir Sahgal, founder and chief medical officer of Essen Health Care, a New York-based integrated healthcare delivery network.
AI in healthcare has shifted from experimental projects to mainstream adoption—reshaping diagnostics, treatment delivery, and healthcare operations. Reveal is positioned as a catalyst in this transition, leveraging a team with academic backgrounds from MIT, Harvard Medical, UC Berkeley and industry experience across Boston Children’s, Mass General, SpaceX, NASA, Athena Health, Infosys, among others.
“We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health,” said Sanchit Mullick, founder of Reveal HealthTech.
Reveal’s flagship platforms include:
BioCanvas – enabling multimodal AI applications, such as accelerating clinical trial recruitment.
Prism AI – enabling rapid development of intelligent agents for workflow automation.
In one recent deployment for a $40 billion U.S. medical device company, Reveal improved patient adherence through AI-powered data integration, creating a reusable blueprint for future clients.
“Meeting with Sanchit, Dr Salim, and the AI leadership team at Reveal made it clear their superpower lies in crafting tailored solutions that demonstrate time-bound, business goodness to clients. We’re very excited to support the team in its next phase of growth,” said Rajul Garg, partner, Leo Capital.
“Healthcare cannot be solved with one-size-fits-all point solutions. Reveal understands that nuance, which is why we backed them from day one. We see an incredible opportunity for Reveal to support the rapid AI adoption within the US healthcare industry,” added Dr. Pankaj Jethwani, managing partner, W Health Ventures.